English Chinese (Simplified) Danish German Greek Icelandic Italian Japanese Korean Russian Spanish Vietnamese
    You are here:
  • Home
Search for:
Search Only:
Total: 13 results found.

Boosting the Immune System

... A GRANT FROM THE PHARMACEUTICALS. All pharmaceuticals have REFUSED to fund Dr. Faustman's studies. Why? we asked, when such a knowledgeable and esteemed researcher has already found a cure for Dt1 in mo ...

The FDA and You - Up Close and Personal

... the FDA have been accused of buying the research patent to studies that show some rate of cure.  This means that neither the original researcher nor other scientists interested in pursuing that line ...

Newsletter # 6 WAITING FOR FDA APPROVAL

... Much has happened since the last newsletter.  Dr. Faustman has had positive results in Phase 1 of her BCG studies, and with as little as 2 injections, has increased C-Peptide production in 2 test ...

Occupy Corporatism and diabetes type 1

... IF as a corporation, their first aim is to make money, the following question looms large: Why would the JDRF fund projects that would reduce or eliminate the influx of donation money, such as studies ...

Economic Benefits of Curing Diabetes type1

... science. …    You’d think that if they were really interested in curing diabetes, they would put Dr. Faustman’s successful studies at the top of their list!   It’s interesting that ...

I haven't a clue how I stumbled onto you

... line to financially support Dr Faustman's phase 2 (and 3) studies are dragging their feet or active in their opposition. How can we lay folks whose contributions can't be but a drop in the bucket ...

Multiple Sclerosis MS and Diabetes Type 1

... several of these CIHR panelists receive research grants and honorariums from pharmaceutical companies, which is a common practice in research. Reference: http://www.leaderpost.com/health/Undisclosed+funding+sources+raise+issue+bias+medical+studies+Report/4405614/story.html ...